Skip to main content
Fig. 3 | Journal of Translational Medicine

Fig. 3

From: Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients

Fig. 3

Development and Kaplan–Meier analyses of a composite nomogram to predict survival. The clinic-molecular nomogram integrated the 9-gene signature. Each component gives points and the sum of the points calculated a linear predictor and overall survival (a). The whole population was divided in 3 subgroups according to the total number of points given by the nomogram: patients at low risk, intermediate risk, and high risk of survival (b)

Back to article page